MCAN Study Published in Pediatric Allergy, Immunology, and Pulmonology
Sponsoring Program Name
Merck Childhood Asthma Network, Inc.
A study published in Pediatric Allergy, Immunology, and Pulmonology examines how tailored evidence-based interventions assist low-income communities with high rates of pediatric asthma morbidity. The study, which examined data from MCAN Phase 1 Program Sites, assessed impact by examining rate of hospitalizations and daily use of a controller medication.
Resource Category
Resource Type
Literacy Level
Target Audience